Riskpilot← Back to searchSign inGet full accessTransire AB
ABActiveOrg 5569127599Vasagatan 21Activities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 20121 employees
Revenue 2025
—
EBITDA margin
—
+8% vs 2024
Equity ratio
72.5%
Financial strength
Net profit 2025
SEK -34K
-113% vs 2024
| Revenue | — | — |
| EBITDA | SEK -34K | +8% |
| Net profit | SEK -34K | -113% |
| Total assets | SEK 717K | -28% |
| Equity | SEK 520K | -31% |
| Employees | 1 | — |
Legal name
Transire AB
Org number
5569127599
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
3 december 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva vård, omsorg och behandling. Psykoterapi, kristerapi och andra former av terapeutiska samtal. Handledning, coachning och föreläsningar. Organisationsutveckling, ledarskapsutveckling och krisarbete samt därmed förenlig verksamhet.
Address
Vasagatan 21
Phone
+46317880898
Email
susanne.lundell@alm-lonn.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −23 | −22 | −37 | −34 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −4 | −23 | −22 | −37 | −34 |
| Net financials | 486 | 686 | 600 | 300 | −0 |
| Profit before tax | 482 | 663 | 578 | 263 | −34 |
| Tax | −0 | — | — | — | — |
| Net profit | 482 | 663 | 578 | 263 | −34 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 440 | 1 641 | 1 234 | 1 002 | 717 |
| Equity | 850 | 1 012 | 990 | 753 | 520 |
| Long-term debt | 419 | 433 | 0 | — | — |
| Short-term debt | 172 | 196 | 244 | 249 | 198 |
| Total debt | 591 | 629 | 244 | 249 | 198 |
EBITDA margin
-3355400.0%
This company
15.8%
Market median
-21236809% vs market
20212025
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
20212025
Return on equity
-6.5%
This company
18.4%
Market median
-135% vs market
20212025
Net profit margin
-3365200.0%
This company
8.1%
Market median
-41545779% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
XC Chief Auditor | Chief Auditor | 2024 |
SE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Transire AB 
Alm & Lönn Psykologmottagning ABBoard members of Transire AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Xuan Cuong Tu | Chief Auditor | 0 companies |
| Susanne Elisabeth Lundell | Chief Executive Officer | 0 companies |
| Kjell Lennart Andersson | Deputy Board Member | 0 companies |